Goshen Health System

Goshen, Indiana 46526

0 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Cervical Cancer, Diffuse Large B Cell Lymphoma (DLBCL), Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies — Completed
• A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) — Completed
• Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer — Stopped early